
    
      This is a single and multiple dose, parallel group study to assess safety and
      pharmacokinetics of oral HTL0018318 in healthy Japanese and Caucasian subjects. The study
      will be conducted in two parts: (A) single doses of HTL0018318 in healthy, adult, male
      Caucasian and Japanese subjects; (B) multiple doses of HTL0018318 in healthy, adult, male
      Caucasian and Japanese subjects.
    
  